Terms: = Head and neck cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Treatment
5 results:
1. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating myh9-Mediated GSK3β/β-Catenin Signaling.
Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
[TBL] [Abstract] [Full Text] [Related]
2. myh9 is a novel cancer stem cell marker and prognostic indicator in esophageal cancer that promotes oncogenesis through the PI3K/AKT/mTOR axis.
Kai JD; Cheng LH; Li BF; Kang K; Xiong F; Fu JC; Wang S
Cell Biol Int; 2022 Dec; 46(12):2085-2094. PubMed ID: 36030536
[TBL] [Abstract] [Full Text] [Related]
3. "myh9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report".
Yabe TE; King K; Russell S; Satgunaseelan L; Gupta R; Chen J; Ashford B
Diagn Pathol; 2022 Feb; 17(1):23. PubMed ID: 35125114
[TBL] [Abstract] [Full Text] [Related]
4. Cisplatin-Mediated Upregulation of APE2 Binding to myh9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury.
Hu Y; Yang C; Amorim T; Maqbool M; Lin J; Li C; Fang C; Xue L; Kwart A; Fang H; Yin M; Janocha AJ; Tsuchimoto D; Nakabeppu Y; Jiang X; Mejia-Garcia A; Anwer F; Khouri J; Qi X; Zheng QY; Yu JS; Yan S; LaFramboise T; Anderson KC; Herlitz LC; Munshi NC; Lin J; Zhao J
Cancer Res; 2021 Feb; 81(3):713-723. PubMed ID: 33288657
[TBL] [Abstract] [Full Text] [Related]
5. FNDC3B 3'-UTR shortening escapes from microRNA-mediated gene repression and promotes nasopharyngeal carcinoma progression.
Li YQ; Chen Y; Xu YF; He QM; Yang XJ; Li YQ; Hong XH; Huang SY; Tang LL; Liu N
Cancer Sci; 2020 Jun; 111(6):1991-2003. PubMed ID: 32232887
[TBL] [Abstract] [Full Text] [Related]
